-
1 Comment
Tianjin Chase Sun Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 2.2% below its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Tianjin Chase Sun Pharmaceutical Co.,Ltd's total revenue rose by 27.0% to $2B since the same quarter in the previous year.
Its net income has increased by 77.4% to $-26M since the same quarter in the previous year.
Finally, its free cash flow grew by 167.5% to $156M since the same quarter in the previous year.
Based on the above factors, Tianjin Chase Sun Pharmaceutical Co.,Ltd gets an overall score of 4/5.
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and sale of various pharmaceutical products in China. The company offers traditional Chinese medicine formula granules; finished drugs, including xuebijing injections, low molecular weight heparin calcium injections, moxifloxacin hydrochloride sodium chloride injections, enoxaparin sodium injections, nadronexacin calcium injections, fasudil hydrochloride injections, ketorheic acid tromethamine injections, ibanoxetine sodium injections, Qingfei Sanjie pills, and Ping Wan anti-cancer pills; raw materials and excipients, such as pharmaceutical excipients, active pharmaceutical ingredients (APIs), and food additives; medical devices, including oxygen concentrators and portable oxygen concentrators; medical and health services; and intelligent supply chain services for pharmaceuticals and medical devices. It also provides chemical reagents, Western patent medicines, enteric casings, heparin sodium, food, beverages, seasonings, tea, candies, and traditional Chinese medicine decoction pieces; pharmaceutical equipment and self-owned housing leasing; pharmaceutical product and medical device research and development; technology consulting, transfer, and promotion; health management, business management, nutritional health, and health information consulting; wholesale and retail of electronic products; import and export of goods and technology; biopharmaceutical project management; project investment; technical service development, transfer, and consulting; consumer electronics and sporting goods sales; computer software and hardware development; general hospital services; nursing services for the elderly and disabled; medical management; diagnosis and treatment; and medical data research activities. The company exports its products to approximately 50 countries and regions. Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300026.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
